Eric H. Schoenstein
Jensen Investment Management
Eric H. Schoenstein Encompass Health Corp stake
total: 257
Jensen Investment Management EHC trades
- Total transactions:
- 29
- New positions:
- 1
- Added:
- 15
- Reduced:
- 13
- Held since:
- 2017 Q4
- Held for:
- 35 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Eric H. Schoenstein holds 39,260 Encompass Health Corp (EHC) shares with a market value of roughly $3.97M accounting for 0.10% of the overall portfolio. To date, the estimated cost basis is nearly $68.8 for "buy" trades and estimated average "sell" price is $91.63. Jensen Investment Management first purchased EHC in 2017 Q4, initially acquiring 15,300 shares. Since the initial investment in Encompass Health Corp (EHC), Jensen Investment Management has made 28 more transactions.
When did Eric H. Schoenstein buy Encompass Health Corp (EHC)?
Eric H. Schoenstein first invested in Encompass Health Corp (EHC) in 2017 Q4 at the reported quarter-end price of $49.41 per share.
What's the cost basis of Jensen Investment Management's EHC stake?
The estimated cost basis for Encompass Health Corp (EHC) stake is around $68.80 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $68.80
- Weighted AVG sell price:
- $91.63
Eric H. Schoenstein's historical trades in Encompass Health Corp
29 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.10%
|
39,260
|
$101.08
|
$3,968,401
|
-22.50% (-11,400)
|
-0.02%
|
|
2025 Q3
|
0.08%
|
50,660
|
$127.02
|
$6,434,833
|
-11.99% (-6,900)
|
-0.01%
|
|
2025 Q2
|
0.08%
|
57,560
|
$122.63
|
$7,058,583
|
-18.74% (-13,270)
|
-0.02%
|
|
2025 Q1
|
0.08%
|
70,830
|
$101.28
|
$7,173,662
|
-13.34% (-10,900)
|
-0.01%
|
|
2024 Q4
|
0.07%
|
81,730
|
$92.35
|
$7,547,766
|
-11.37% (-10,480)
|
-0.01%
|
|
2024 Q3
|
0.07%
|
92,210
|
$96.64
|
$8,911,174
|
-2.33% (-2,200)
|
-0%
|
|
2024 Q2
|
0.07%
|
94,410
|
$85.79
|
$8,099,434
|
-6.10% (-6,130)
|
-0%
|
|
2024 Q1
|
0.06%
|
100,540
|
$82.58
|
$8,302,593
|
-4.74% (-5,000)
|
-0%
|
|
2023 Q3
|
0.06%
|
105,540
|
$67.16
|
$7,088,066
|
-14.01% (-17,200)
|
-0.01%
|
|
2023 Q2
|
0.06%
|
122,740
|
$67.71
|
$8,310,725
|
-3.11% (-3,940)
|
-0%
|
|
2022 Q4
|
0.06%
|
$59.81
|
-4.75% (-6,320)
|
|||
|
2022 Q2
|
0.06%
|
$56.05
|
+5.15% (+6,520)
|
|||
|
2022 Q1
|
0.07%
|
$71.11
|
+27.44% (+27,230)
|
|||
|
2021 Q4
|
0.05%
|
$65.26
|
+10.08% (+9,090)
|
|||
|
2021 Q3
|
0.05%
|
$75.04
|
+44.12% (+27,600)
|
|||
|
2021 Q2
|
0.04%
|
$78.04
|
+8.72% (+5,020)
|
|||
|
2021 Q1
|
0.04%
|
$81.91
|
+40.41% (+16,560)
|
|||
|
2020 Q4
|
0.03%
|
$82.70
|
+12.18% (+4,450)
|
|||
|
2020 Q3
|
0.02%
|
$64.99
|
+34.90% (+9,450)
|
|||
|
2020 Q2
|
0.02%
|
$61.93
|
+19.24% (+4,370)
|
|||
|
2020 Q1
|
0.02%
|
$64.02
|
-10.34% (-2,620)
|
|||
|
2019 Q4
|
0.02%
|
$69.29
|
+2.47% (+610)
|
|||
|
2019 Q3
|
0.02%
|
$63.27
|
+12.77% (+2,800)
|
|||
|
2019 Q2
|
0.02%
|
$63.37
|
+7.87% (+1,600)
|
|||
|
2019 Q1
|
0.01%
|
$58.42
|
+18.62% (+3,190)
|
|||
|
2018 Q4
|
0.01%
|
$61.70
|
+16.29% (+2,400)
|
|||
|
2018 Q3
|
0.01%
|
$77.94
|
-8.00% (-1,280)
|
|||
|
2018 Q1
|
0.01%
|
$57.15
|
+4.64% (+710)
|
|||
|
2017 Q4
|
0.01%
|
$49.41
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.